دورية أكاديمية
Patients' views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study.
| العنوان: | Patients' views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study. |
|---|---|
| المؤلفون: | Al Rowily A; School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, Sir Robert Aitken Institute for Medical Research, University of Birmingham, Birmingham, B15 2TT, UK. axa1320@student.bham.ac.uk.; Pharmaceutical Care Department, King Fahad Military Medical Complex (KFMMC), Medical Department, Ministry of Defence, Dhahran, Saudi Arabia. axa1320@student.bham.ac.uk., Baraka MA; College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates., Abutaleb MH; Pharmaceutical Care Department, King Fahd Central Hospital, Jazan Health Affairs, Ministry of Health, Jazan, Saudi Arabia., Alhayyan AM; Third Health Cluster, AL-Diriyah Hospital, Riyadh, Saudi Arabia., Aloudah N; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Jalal Z; School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, Sir Robert Aitken Institute for Medical Research, University of Birmingham, Birmingham, B15 2TT, UK., Paudyal V; School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, Sir Robert Aitken Institute for Medical Research, University of Birmingham, Birmingham, B15 2TT, UK. |
| المصدر: | Journal of pharmaceutical policy and practice [J Pharm Policy Pract] 2023 May 01; Vol. 16 (1), pp. 58. Date of Electronic Publication: 2023 May 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Informa UK Limited Country of Publication: England NLM ID: 101627192 Publication Model: Electronic Cited Medium: Print ISSN: 2052-3211 (Print) Linking ISSN: 20523211 NLM ISO Abbreviation: J Pharm Policy Pract Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2024- : London : Informa UK Limited Original Publication: London : BioMed Central, 2013- |
| مستخلص: | Background: Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients' views and experiences of DOACs use and factors that can promote safety associated with DOACs. Methods: In-depth interviews were conducted with adult patients who had been prescribed DOACs, identified and invited by local collaborators in three different tertiary care hospitals in Saudi Arabia. A topic guide developed based on was used to inform the interview. Data were analysed thematically. Results: Data saturation was achieved by the ninth participants. Three major themes were identified: (1) factors affecting DOAC's safety from the patients view; (2) barriers to adherence to DOACs and (3) strategies to promote the safety of DOACs. Lack of knowledge of DOACs, using inappropriate sources of information, lack of communication with HCPs, difficulty in having access to DOACs and lack of monitoring were the main factors affecting the safe use of DOACs. Unavailability of the drugs and difficulty in timely getting to hospitals affected adherence. Patients acknowledged difficulties communicating with healthcare professionals, timely access to anticoagulation clinics and in obtaining their DOACs on time. Conclusions: There is a need to develop and evaluate theory-based interventions to promote patient knowledge, understanding and shared decision-making to optimise DOACs use and improve their safety. (© 2023. Crown.) |
| References: | Eur J Clin Pharmacol. 2022 Apr;78(4):623-645. (PMID: 34935068) Br J Clin Pharmacol. 2019 Nov;85(11):2464-2478. (PMID: 31486099) Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e56-e61. (PMID: 32576572) Int J Clin Pharm. 2022 Aug;44(4):1057-1066. (PMID: 35731467) Circ Res. 2020 Jun 19;127(1):4-20. (PMID: 32716709) Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):615-21. (PMID: 22949490) Br J Clin Pharmacol. 2018 Jul;84(7):1544-1556. (PMID: 29522647) Am J Health Syst Pharm. 2013 Jan 15;70(2):113-25. (PMID: 23292264) Am J Med. 2011 Dec;124(12):1136-42. (PMID: 22114827) Patient. 2014;7(1):47-54. (PMID: 24030706) Int J Clin Pharm. 2021 Dec;43(6):1693-1704. (PMID: 34215959) J Thromb Thrombolysis. 2019 Jan;47(1):146-154. (PMID: 30298305) Open Heart. 2020 Apr 6;7(1):e001257. (PMID: 32509316) Europace. 2010 May;12(5):626-33. (PMID: 20421224) J Pharm Policy Pract. 2021 Oct 1;14(1):81. (PMID: 34598728) |
| معلومات مُعتمدة: | MD436 Saudi Arabia Cultural Bureau in London |
| فهرسة مساهمة: | Keywords: DOACs; Direct oral anticoagulants; Interviews; Medication errors; Patient experience; Patients; Qualitative research |
| تواريخ الأحداث: | Date Created: 20230501 Latest Revision: 20230503 |
| رمز التحديث: | 20230503 |
| مُعرف محوري في PubMed: | PMC10150668 |
| DOI: | 10.1186/s40545-023-00563-y |
| PMID: | 37127790 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
PDF full text from Publisher 
Full Text Finder | تدمد: | 2052-3211 |
|---|---|
| DOI: | 10.1186/s40545-023-00563-y |